Clinical Trial Update: Phase 4 Study of Effect of Aspirin on Flushing in Dimethyl Fumarate-Treated Participants With Relapsing-Remitting Multiple Sclerosis [Phase 4]

View source ↗

Summary

Phase 4 trial evaluating whether aspirin mitigates flushing in patients with relapsing-remitting multiple sclerosis treated with dimethyl fumarate; the study is…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Relapsing-remitting Multiple Sclerosis

Drugs mentioned

• Aspirin (Aspirin)
• Tecfidera (dimethyl fumarate)

Snippet

Sponsor: Biogen | Conditions: Relapsing-Remitting Multiple Sclerosis | Phase 4 | Status: COMPLETED | Results posted: 2016-12-28